← Back to Search

Self-Management Intervention for HIV+ Asian Pacific Americans

N/A
Recruiting
Research Sponsored by University of California, Los Angeles
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Participants must self-identify as men
Participants must be at least 18 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 10
Awards & highlights

Study Summary

This trial adapts and evaluates a 4-session self-management intervention to promote health among Asian Pacific American men with HIV. The intervention is designed to help APAMHIV secure family support and improve health outcomes.

Who is the study for?
This trial is for HIV-positive Asian Pacific American men who are at least 18 years old, currently on antiretroviral therapy (ART), and healthy enough to attend counseling sessions. They must be able to give informed consent and communicate in English or a major Asian language.Check my eligibility
What is being tested?
The study is testing a family-informed self-management intervention over four weeks, designed to help these individuals secure family support and promote health. The goal is to see if this approach can improve health outcomes for HIV-positive APA men.See study design
What are the potential side effects?
Since the intervention involves counseling sessions rather than medication, there may not be physical side effects. However, participants might experience emotional discomfort discussing personal issues related to their condition.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I identify as a man.
Select...
I am 18 years old or older.
Select...
I am currently on antiretroviral therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 10
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 10 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Biomarker
Quality of life after Self-management intervention

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Immediate Treatment (IT)Experimental Treatment1 Intervention
This small RCT will contain two arms, with participants randomly assigned to either the immediate treatment group (IT Group) or the delayed treatment group (DT Group).
Group II: Delay Treatment (DT)Active Control1 Intervention
This small RCT will contain two arms, with participants randomly assigned to either the immediate treatment group (IT Group) or the delayed treatment group (DT Group).

Find a Location

Who is running the clinical trial?

University of California, Los AngelesLead Sponsor
1,538 Previous Clinical Trials
10,267,001 Total Patients Enrolled
Apait Health CenterOTHER

Media Library

Self-Management for HIV-positive Asian Pacific Americans Clinical Trial Eligibility Overview. Trial Name: NCT04353739 — N/A
Self-Management Research Study Groups: Immediate Treatment (IT), Delay Treatment (DT)
Self-Management Clinical Trial 2023: Self-Management for HIV-positive Asian Pacific Americans Highlights & Side Effects. Trial Name: NCT04353739 — N/A
Self-Management for HIV-positive Asian Pacific Americans 2023 Treatment Timeline for Medical Study. Trial Name: NCT04353739 — N/A
~20 spots leftby Jun 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top